Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter
Ww. Noll et al., Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter, AM J PATH, 158(2), 2001, pp. 691-697
Citations number
36
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Matrix metalloproteinase-1 (MMP-1, collagenase-1). which degrades interstit
ial collagen, is expressed at high levels by some tumor cells and is though
t to enhance their invasiveness and metastatic potential. We recently descr
ibed a common single nucleotide insertion polymorphism (2G allele) at -1,60
7 bp in the promoter of the MMP-1 gene that creates a binding site for the
ETS family of transcription factors, and that is associated with enhanced t
ranscription of this gene and increased enzyme activity. Allelic loss at th
e MMP-1 locus on chromosome 11 occurs in many tumors including melanoma, an
invasive and aggressive cancer. We hypothesized that although loss of eith
er the 1G or 2G allele from 1G/2G heterozygotes is random, retention of the
transcriptionally more active 2G allele would, favor tumor invasion and me
tastasis, As a result, a higher proportion of metastases would contain the
2G genotype than the 1G genotype. We report here the development of quantit
ative methods for assessing allelic loss at the MMP-1 locus, and demonstrat
e that 83% of the metastatic melanomas with loss of heterozygosity at this
locus retained the 2G allele. This supports the hypothesis that retention o
f the 2G allele favors tumor invasion and metastasis in melanoma.